Skip to content

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain: An Open-labeled, Single-arm, Exploratory Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03315598
Enrollment
22
Registered
2017-10-20
Start date
2017-05-15
Completion date
2018-02-23
Last updated
2022-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Neuropathy, Painful, Failed Back Surgery Syndrome, Neuralgia, Neuralgia; Postherpetic

Keywords

Neuralgia, Acupuncture Treatment

Brief summary

The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.

Detailed description

The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome. * Postherpetic neuralgia * Failed back surgery syndrome * Diabetic neuropathy * other peripheral neuropathy Patients with refractory neuropathic pain who do not respond to conservative treatment for more than 3 months should be included. Acupuncture treatment is maintained for 2 months in oriental medicine hospital. The effect is evaluated through the numeric rating score and the validated questionnaire.

Interventions

PROCEDUREElectroacupuncture

lectroacupuncture is a form of acupuncture where a small electric current is passed between pairs of acupuncture needles. According to some acupuncturists, this practice augments the use of regular acupuncture, can restore health and well-being, and is particularly good for treating pain.

Sponsors

Seoul National University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who can adequately write a reportable questionnaire * Patients who have been diagnosed with one of the following neuropathic pain disease (postherpetic neuralgia, failed back surgery syndrome, diabetic neuropathy, other peripheral neuropathy) * Patients who failed conservative treatment at Seoul National University Hospital for more than 3 months. * Patients with NRS 5 points or more * Patients with painDETECT score 19 points or more

Exclusion criteria

* Patients with major mental illness * Patients with unstable medical conditions * Pregnant * Patients who received acupuncture treatment at the site within the past month * Patients with bleeding tendency * Patients taking immunosuppressive drugs

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Numeric rating scale pain score (0-10) at 4 weeksAt 4-week follow-up visitThe Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).
Change from baseline Numeric rating scale pain score (0-10) at 8 weeksAt 8-week follow-up visitThe Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).

Secondary

MeasureTime frameDescription
Change from the score of the short-form McGill Pain Questionnaire at 8 weeksAt 8-week follow-up visitThe main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe. Three pain scores are derived from the sum of the intensity rank values of the words chosen for sensory, affective and total descriptors. The SF-MPQ also includes the Present Pain Intensity (PPI) index of the standard MPQ and a visual analogue scale (VAS).
Change from baseline score of Brief Pain Inventory Short Form (BFI-SF) at 8 weeksAt 8-week follow-up visitThe Brief Pain Inventory (BPI) rapidly assesses the severity of pain and its impact on functioning.
Patients' Global Impression of Change (PGIC) scaleAt 8-week follow-up visitThe self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment. 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.
5-pointed patient satisfaction scaleAt 8-week follow-up visitThe 5-pointed patient satisfaction scale is an 5-point scale for patient self-reporting of satisfaction with treatment. 1. Very satisfied 2. Satisfied 3. Neither satisfied nor dissatisfied 4. Dissatisfied 5. Very dissatisfied

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026